[PLX] QoQ Quarter Result on 30-Sep-2011 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- 35.17%
YoY- -258.73%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 26,113 3,728 2,362 1,132 764 6,000 1,176 691.50%
PBT 22 0 968 0 179 -5,052 22,414 -99.01%
Tax -8,765 -161 -27,616 108 20,699 0 -20,470 -43.21%
NP 9,642 -5,904 -8,913 -8,875 -13,689 -5,052 -8,528 -
Tax Rate 39,840.91% - 2,852.89% - -11,563.69% - 91.33% -
Total Cost 16,471 9,632 11,275 10,007 14,453 11,052 9,704 42.33%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 36.92 -158.37 -377.35 -784.01 -1,791.75 -84.20 -725.17 -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
EPS 0.11 -0.07 -1.01 -0.10 -0.16 -0.06 -1.04 -
EPS Diluted 0.10 -0.07 -1.01 -0.10 -0.16 -0.06 -1.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.